- Report
- December 2025
- 79 Pages
Global
From €2597EUR$2,950USD£2,245GBP
- Report
- December 2025
- 166 Pages
Global
From €4094EUR$4,650USD£3,538GBP
- Report
- July 2025
- 117 Pages
Global
From €4094EUR$4,650USD£3,538GBP
- Report
- February 2026
- 250 Pages
Global
From €3953EUR$4,490USD£3,416GBP
- Report
- January 2026
- 197 Pages
Global
From €3121EUR$3,545USD£2,697GBP
€3468EUR$3,939USD£2,997GBP
- Report
- January 2026
- 181 Pages
Global
From €3121EUR$3,545USD£2,697GBP
€3468EUR$3,939USD£2,997GBP
- Report
- August 2025
- 192 Pages
Global
From €3121EUR$3,545USD£2,697GBP
€3468EUR$3,939USD£2,997GBP
- Report
- August 2025
- 199 Pages
Global
From €3121EUR$3,545USD£2,697GBP
€3468EUR$3,939USD£2,997GBP
- Report
- August 2025
- 195 Pages
Global
From €3121EUR$3,545USD£2,697GBP
€3468EUR$3,939USD£2,997GBP
- Report
- December 2025
- 200 Pages
Global
From €2192EUR$2,490USD£1,895GBP
- Report
- July 2025
- 128 Pages
Global
From €4314EUR$4,900USD£3,728GBP
- Report
- March 2026
- 140 Pages
Global
From €3521EUR$3,999USD£3,043GBP
- Report
- March 2026
- 136 Pages
Global
From €3521EUR$3,999USD£3,043GBP
- Report
- August 2025
- 149 Pages
Global
From €3521EUR$3,999USD£3,043GBP
- Report
- October 2025
- 150 Pages
Global
From €3521EUR$3,999USD£3,043GBP
- Report
- October 2025
- 144 Pages
Global
From €3521EUR$3,999USD£3,043GBP
- Report
- September 2025
- 147 Pages
Global
From €3521EUR$3,999USD£3,043GBP
- Report
- September 2025
- 142 Pages
Global
From €3521EUR$3,999USD£3,043GBP
- Report
- January 2026
- 120 Pages
Global
From €5238EUR$5,950USD£4,527GBP
- Report
- December 2025
- 120 Pages
Global
From €5238EUR$5,950USD£4,527GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more